Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ITMCTR2026001073) titled 'A randomized controlled trial of acupuncture for oxaliplatin-induced peripheral neuropathy at different altitudes based on immune balance' on April 24.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China
Condition:
Gastric cancer and colorectal cancer
Intervention:
Highland/Plain Acupuncture Group:Acupuncture will be administered in combination with oxaliplatin-based chemotherapy and standard of care treatment, with each treatment cycle lasting 21 days: On Day 1 of each cycle, participants will ...